Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Industry: Biotechnology
Sector: Healthcare
Phone: (713) 335-5697
Fax: (713) 935-0649
Address:
9432 Katy Freeway, Houston, United States
